426 related articles for article (PubMed ID: 9517580)
1. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Feng W; Garrett H; Speert DP; King M
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
[TBL] [Abstract][Full Text] [Related]
2. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
King M; Dasgupta B; Tomkiewicz RP; Brown NE
Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
[TBL] [Abstract][Full Text] [Related]
3. Effects of dextran sulfate on tracheal mucociliary velocity in dogs.
Sudo E; Boyd WA; King M
J Aerosol Med; 2000; 13(2):87-96. PubMed ID: 11010598
[TBL] [Abstract][Full Text] [Related]
4. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
Dasgupta B; King M
Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
[TBL] [Abstract][Full Text] [Related]
5. Is cystic fibrosis mucus abnormal?
King M
Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
[TBL] [Abstract][Full Text] [Related]
6. Effects of dextran on tracheal mucociliary velocity in dogs in vivo.
Feng W; Nakamura S; Sudo E; Lee MM; Shao A; King M
Pulm Pharmacol Ther; 1999; 12(1):35-41. PubMed ID: 10208834
[TBL] [Abstract][Full Text] [Related]
7. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
App EM; Kieselmann R; Reinhardt D; Lindemann H; Dasgupta B; King M; Brand P
Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
[TBL] [Abstract][Full Text] [Related]
8. The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis.
Homnick DN; Marks JH; Rubin BK
J Aerosol Med; 2007; 20(1):45-9. PubMed ID: 17388752
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic aerosols and airway secretions.
Rubin BK
J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
[TBL] [Abstract][Full Text] [Related]
10. Additive effect of dornase alfa and Nacystelyn on transportability and viscoelasticity of cystic fibrosis sputum.
Sun F; Tai S; Lim T; Baumann U; King M
Can Respir J; 2002; 9(6):401-6. PubMed ID: 12522485
[TBL] [Abstract][Full Text] [Related]
11. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease.
Dasgupta B; Brown NE; King M
Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074
[TBL] [Abstract][Full Text] [Related]
12. Cystic Fibrosis Sputum Rheology Correlates With Both Acute and Longitudinal Changes in Lung Function.
Ma JT; Tang C; Kang L; Voynow JA; Rubin BK
Chest; 2018 Aug; 154(2):370-377. PubMed ID: 29559310
[TBL] [Abstract][Full Text] [Related]
13. Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Shibuya Y; Wills PJ; Cole PJ
Respirology; 2003 Jun; 8(2):181-5. PubMed ID: 12753533
[TBL] [Abstract][Full Text] [Related]
14. Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.
Deneuville E; Perrot-Minot C; Pennaforte F; Roussey M; Zahm JM; Clavel C; Puchelle E; de Bentzmann S
Am J Respir Crit Care Med; 1997 Jul; 156(1):166-72. PubMed ID: 9230742
[TBL] [Abstract][Full Text] [Related]
15. Physical and transport properties of sputum from children with idiopathic bronchiectasis.
Redding GJ; Kishioka C; Martinez P; Rubin BK
Chest; 2008 Dec; 134(6):1129-1134. PubMed ID: 18753467
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus.
Zahm JM; Girod de Bentzmann S; Deneuville E; Perrot-Minnot C; Dabadie A; Pennaforte F; Roussey M; Shak S; Puchelle E
Eur Respir J; 1995 Mar; 8(3):381-6. PubMed ID: 7789481
[TBL] [Abstract][Full Text] [Related]
17. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.
Shibuya Y; Wills PJ; Cole PJ
Respiration; 2001; 68(6):615-9. PubMed ID: 11786718
[TBL] [Abstract][Full Text] [Related]
18. The effect of tasuldine, a bronchosecretolytic agent, on mucus rheology and clearability and the interaction with acetylcholine in ferrets.
App EM; Tomkiewicz RP; Hahn HL; Engler H; Vergin H; King M
Pulm Pharmacol Ther; 1997; 10(5-6):271-6. PubMed ID: 9778490
[TBL] [Abstract][Full Text] [Related]
19. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis.
Aquino ES; Shimura F; Santos AS; Goto DM; Coelho CC; de Fuccio MB; Saldiva PH; Lorenzi-Filho G; Rubin BK; Nakagawa NK
Respir Care; 2012 Nov; 57(11):1914-9. PubMed ID: 22417659
[TBL] [Abstract][Full Text] [Related]
20. Combined use of rheology and portable low-field NMR in cystic fibrosis patients.
Abrami M; Maschio M; Conese M; Confalonieri M; Gerin F; Dapas B; Farra R; Adrover A; Torelli L; Ruaro B; Grassi G; Grassi M
Respir Med; 2021; 189():106623. PubMed ID: 34624628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
